ADVERTISEMENT

ADVERTISEMENT

Indian-origin scientist secures Rita Allen grant for pain research

University of Washington immunologist Aakanksha Jain is among seven early-career researchers selected for the prestigious 2026 Rita Allen Foundation Scholars program.

 Aakanksha Jain has been selected as a Rita Allen Foundation Scholar for her research on chronic pain and immune system interactions. Aakanksha Jain has been selected as a Rita Allen Foundation Scholar for her research on chronic pain and immune system interactions. / Aakanksha Jain/X

Indian-origin scientist Aakanksha Jain, an assistant professor of immunology at the University of Washington, has been named one of seven recipients of the prestigious 2026 Rita Allen Foundation Scholars award, a program that supports promising early-career biomedical researchers across the United States.

The Rita Allen Foundation announced the new class of scholars on June 11, recognizing researchers whose work could lead to major advances in neuroscience, cancer, immunology and pain treatment. Awardees receive grants of up to $110,000 annually for up to five years to pursue high-risk, high-impact scientific research.

Also Read: Johns Hopkins professor Anand Bhattad earns ICRA Best Paper honor

Jain, who earned her bachelor's degree in engineering from the National Institute of Technology Warangal before completing a Ph.D. at the University of Texas Southwestern Medical Center, was selected for her work examining how the immune system contributes to chronic pain.

Her research focuses on T cells, immune cells traditionally known for fighting infections and cancer, and their role in neuropathic pain. Jain's laboratory has found that T cells infiltrate damaged nerves and display characteristics similar to those seen in autoimmune diseases, raising the possibility that nerve injuries may trigger autoimmune-like responses that contribute to long-term pain.

"We aim to apply principles from autoimmune disease research to understand mechanisms of neuropathic pain with the long-term goal of immune-based therapies for chronic pain," Jain said in a statement released by the foundation.

She noted that the award will allow her to pursue ambitious research at the intersection of immunology and neuroscience, an area that is often difficult to support through traditional funding mechanisms.

The 2026 cohort also includes researchers from institutions such as the University of California, San Francisco; Columbia University; Cornell University; Cold Spring Harbor Laboratory; Stanford University; and Cincinnati Children's Hospital Medical Center.

Among the other projects selected this year are studies exploring how drugs can better reach the brain, how cellular signaling may unlock new treatments for cancer and autoimmune disorders, how ancient genetic elements protect brain development, and how metabolism influences aging and disease.

Since its launch in 1976, the Rita Allen Foundation Scholars program has supported more than 225 biomedical researchers. Alumni of the program have gone on to receive some of science's highest honors, including the Nobel Prize, the National Medal of Science and the Breakthrough Prize in Life Sciences.

For Jain, the recognition places her among a new generation of scientists tackling some of medicine's most challenging unanswered questions, with potential implications for millions living with chronic pain worldwide.

Discover more at New India Abroad.

Comments

Related